TNFSF11 and cancer: Alternatively, bisphosphonate and anti-receptor activator of nuclear factor κB ligand (RANKL) antibody treatments that decrease bone resorption in cancer patients with bone metastases [9,10], and radium-223 which forms complexes with hydroxylapatite in bone [11,12,13] can also reduce the onset of pain.